Exhibit 5.1





(914) 993-6054


June 29, 2021                         


Sachem Capital Corp.

698 Main Street

Branford, Connecticut 06405


Re: 7.75% Series A Cumulative Redeemable Preferred Stock


Ladies and Gentlemen:


We have acted as special counsel to Sachem Capital Corp., a New York corporation (the “Company”), in connection with the public offering of 1,700,000 shares of its 7.75% Series A Cumulative Redeemable Preferred Stock, par value $0.001 per share (the “Shares”). The offering was made pursuant to a prospectus supplement, dated June 23, 2021 (the “Prospectus Supplement”), and a base prospectus, dated June 17, 2021 (the “Base Prospectus” and, together with the Prospectus Supplement, the “Prospectus”), which are part of a “shelf” registration statement on Form S-3, SEC File No. 333-256940 (the “Registration Statement”) filed by the Company with the Securities and Exchange Commission (the “Commission”) pursuant to the Securities Act of 1933, as amended (the “Securities Act”), which was declared effective by the Commission on June 17, 2021, registering for sale by the Company of up to $150 million of its securities, including common shares, par value $0.001 per share, preferred shares, par value $0.001 per share, debt securities, warrants and units. The Shares were created pursuant to a Certificate of Amendment to the Company’s Certificate of Incorporation (the “Certificate of Amendment”) filed with the New York Department of State prior to the date hereof.


This opinion is being furnished in accordance with the requirements of Item 601(b)(5) of Regulation S-K under the Securities Act.


With respect to the opinion set forth below, we have examined originals, certified copies, or copies otherwise identified to our satisfaction as being true copies, of the following (the “Documents”):


1.The Certificate of Incorporation of the Company, as amended to date including the Certificate of Amendment;
2.The Bylaws of the Company, as amended to date;
3.The Registration Statement;
4.The Prospectus;
5.The Underwriting Agreement, dated June 23, 2021 (the “Underwriting Agreement”), by and between the Company and Ladenburg Thalmann & Co. Inc., as representative of the several underwriters listed in Schedule I to the Underwriting Agreement (the “Underwriters”);
6.The resolutions of the board of directors of the Company (i) relating to the filing of the Prospectus Supplement and the transactions described therein, (ii) authorizing the issuance and sale of the Shares, and (iii) approving the execution, delivery and performance of the Underwriting Agreement and the Certificate of Amendment; and





Sachem Capital Corp.

June 29, 2021

Page 2


7.Such other documents, records and other instruments as we have deemed appropriate for purposes of the opinion set forth herein.


In rendering the opinion set forth below, we have assumed the genuineness of all signatures, the legal capacity of natural persons, the authenticity of all documents submitted to us as originals, the conformity to original documents of all documents submitted to us as duplicates or certified or conformed copies and the authenticity of originals or such documents and that each of the parties (other than the Company) executing any of the Documents has duly and validly executed and delivered each of the Documents to which such party is a signatory, and the obligations of each party set forth therein are legal, valid and binding and are enforceable in accordance with all stated terms. As to various questions of fact material to this opinion, we have relied, to the extent we deemed reasonably appropriate, upon representations of officers or directors of the Company and upon such certificates, records, instruments and other documents furnished to us by the Company, without independently checking or verifying the accuracy of such certificates, documents, records, instruments and other documents.


Based solely upon and subject to the foregoing, and subject to the assumptions, limitations and qualifications stated herein, we are of the opinion that the Shares have been duly authorized for issuance and when executed, issued and authenticated in accordance with the terms of the Certificate of Amendment, and delivered to and paid for by the Underwriters in accordance with the terms of the Underwriting Agreement, will be the legally valid and binding obligations of the Company, enforceable against the Company under the laws of the State of New York in accordance with their terms.


This opinion letter is limited to the matters stated herein and no opinions may be implied or inferred beyond the matters expressly stated herein. We do not express any opinion herein concerning any law other than the laws of the State of New York and the securities laws of the United States. Further, our opinion is based solely upon existing laws, rules and regulations and we undertake no obligation to advise you of any changes that may be brought to our attention after the date hereof.


The opinion set forth above is subject to (i) the effects of bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium, and other similar laws now or hereafter in effect relating to or affecting creditors’ rights generally; (ii) the effects of general equitable principles, including, without limitation, concepts of materiality, reasonableness, good faith and fair dealing, and the possible unavailability of specific performance or injunctive relief, whether enforcement is considered in a proceeding in equity or law; (iii) the discretion of the court before which any proceeding for enforcement may be brought; and (iv) the unenforceability under certain circumstances under law or court decisions of provisions providing for the indemnification of or contribution to a party with respect to a liability where such indemnification or contribution is contrary to public policy.





Sachem Capital Corp.

June 29, 2021

Page 3


We consent to the filing of this opinion as an exhibit to the Current Report on Form 8-K relating to the issuance of the Shares to be filed by the Company in connection with the offering and sale of the Shares, which Current Report is incorporated by reference into the Registration Statement, and to the reference to this firm under the caption “Legal Matters” in the Prospectus Supplement constituting a part of the Registration Statement. In giving this consent, we do not admit that we are experts or within the category of persons whose consent is required under Section 7 of the Securities Act.



  Very truly yours,
  By: /s/Katherine R. Steiner
    Katherine R. Steiner, Partner